The trademark application NEOTIL was filed by Ludwig Institute for Cancer Research Ltd., a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on April 3, 2022, and it was registered by office on July 11, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for use in cell therapy
Pharmaceutical preparations for use in immunology and oncology
Personalized cell preparations for the treatment of cancer
Biological preparations for the identification and treatment of cancer and oncological conditions
Cell preparations and treatments containing cells, and lymphocytes for medical and clinical use
Cells for medical use.
The mark was filed in class 40 with Custom manufacture of biopharmaceuticals.
The mark was filed in class 42 with following description of goods:
Laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, biological and biotechnological substances and biomanufacturing
Development and production of pharmaceuticals
Research and development of pharmaceuticals and pharmaceutical treatments